Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Equity (2020 - 2025)

Oncology Institute's Return on Equity history spans 6 years, with the latest figure at 4.33% for Q4 2025.

  • For Q4 2025, Return on Equity rose 1111.0% year-over-year to 4.33%; the TTM value through Dec 2025 reached 4.33%, up 1111.0%, while the annual FY2025 figure was 9.99%, 1213.0% up from the prior year.
  • Return on Equity reached 4.33% in Q4 2025 per TOI's latest filing, down from 6.24% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 33.65% in Q2 2025 to a low of 14.87% in Q1 2025.
  • Average Return on Equity over 5 years is 0.59%, with a median of 0.29% recorded in 2021.
  • The largest YoY upside for Return on Equity was 3568bps in 2025 against a maximum downside of -1338bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.14% in 2021, then surged by 101bps to 0.0% in 2022, then tumbled by -106585bps to 1.29% in 2023, then crashed by -426bps to 6.78% in 2024, then soared by 164bps to 4.33% in 2025.
  • Per Business Quant, the three most recent readings for TOI's Return on Equity are 4.33% (Q4 2025), 6.24% (Q3 2025), and 33.65% (Q2 2025).